Crp Risk Management Ltd vs Qualitek Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 20, 2026

Key Highlights

The Latest Trading Price of CRP Risk Management Ltd is ₹ 6.18 as of 15 Apr 15:30 . The P/E Ratio of CRP Risk Management Ltd is 0 as of March 2021 .The P/E Ratio of Qualitek Labs Ltd is 0 as of March 2021 . The Market Cap of CRP Risk Management Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Qualitek Labs Ltd is ₹ 0 crore as of March 2021 . The Dividend Payout of CRP Risk Management Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Qualitek Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About CRP Risk Management Ltd

CRP Risk Management Limited was originally incorporated as a private limited company with the name 'CRP Technologies (India) Private Limite'.
Subsequently, the Company was converted into a public limited company and the name of the Company was changed to 'CRP Technologies (India) Limited' on June 23, 2011.
Subsequently, the name of the company was further changed to 'CRP Risk Management Limited? on November 17, 2014. CRP Risk is a risk management and risk mitigation enterprise.
The Company verifies critical information for large and mid-sized corporate.
It provides the services to multiple departments like Finance, Compliance, Operations etc.

About Qualitek Labs Ltd

Qualitek Labs Limited was incorporated as 'Qualitek Labs Private Limited' at New Delhi as a Private Limited Company, pursuant to Certificate of Incorporation dated May 17, 2018 issued by Registrar of Companies, New Delhi.
Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Qualitek Labs Limited' vide a Fresh Certificate of Incorporation issued by the Registrar of Companies, New Delhi on April 26, 2023. The Promoters and Directors, Mr Alok Kumar Agarwal, Mr. Kamal Grover and Mr. Antaryami Nayak established the Company for testing, inspection and certification business in year 2018.
Qualitek Labs has a system of internal controls to ensure that all the assets are safeguarded and productive.
Company is engaged in the business of providing Testing, Inspection and Certification services in the fields of Automobiles, Defence, Electronics & Electricals, Pharmaceuticals, Medical Devices, Metals, Minerals, Environment Monitoring, Food, Water etc.

FAQs for the comparison of CRP Risk Management Ltd and Qualitek Labs Ltd

Which company has a larger market capitalization, CRP Risk Management Ltd or Qualitek Labs Ltd?

Market cap of CRP Risk Management Ltd is 10 Cr while Market cap of Qualitek Labs Ltd is 420 Cr

What are the key factors driving the stock performance of CRP Risk Management Ltd and Qualitek Labs Ltd?

The stock performance of CRP Risk Management Ltd and Qualitek Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for CRP Risk Management Ltd and Qualitek Labs Ltd?

As of March 20, 2026, the CRP Risk Management Ltd stock price is INR ₹6.18. On the other hand, Qualitek Labs Ltd stock price is INR ₹361.0.

How do dividend payouts of CRP Risk Management Ltd and Qualitek Labs Ltd compare?

To compare the dividend payouts of CRP Risk Management Ltd and Qualitek Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.